Please assess the completion status of the following clinical trial:

Trial Title: A Phase II Multi Centre Study to Assess the Safety and Performance of Two Prototype One Piece Pouches in Subjects With an Ileostomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects who provide written informed consent.~* Subjects who have an ileostomy and be over 18 years of age.~* Subjects who are currently using a one piece drainable pouch.~* Subjects who have unbroken peri-stomal skin (healthy normal skin defined as normal unbroken skin with certain variations normal for this subject to L1 on the SACs Instrument Scale).~* Subjects with a stoma considered 'normal' in appearance in accordance with the stoma, colour, moisture and structure rating scales.~* Subjects who are willing to attend clinic for a maximum of 5 separate occasions for scheduled visits.~* Subjects who are willing to discontinue the use of pastes, adhesive strips and rings/seals used to seal the area between the skin barrier wafer and stoma during the use of the study device.~* Subjects who other than their ileostomy considered to have a healthy/stable health status.~* Subjects who have good manual dexterity and be able to take care of their stoma independently, or have a consistent care provider.~* Subjects who are willing and able to complete a diary card for the duration of the study.~Exclusion Criteria:~* Subjects with a history of sensitivity to any one of the ostomy products or the components being studied.~* Subjects with stoma duration of less than 3 months.~* Subjects who currently use a belt with their usual appliance.~* Subjects who have been entered into the study before, or who have previously taken part in a study in the last month.~* Subjects who require convexity or other skin fillers (pastes, rings, seals) to even undulations of the skin.~* Subjects undergoing chemotherapy or radiotherapy.~* Subjects who have any other medical condition which, according to the investigator justifies exclusion from the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Type A Pouch followed by Type B pouch (Type: EXPERIMENTAL): Enhanced one piece drainable pouch with Type A mouldable adhesive for Stage 1 and 2 followed by pouch with Type B mouldable adhesive for Stage 3
- Type B Pouch followed by Type A pouch (Type: EXPERIMENTAL): Enhanced one piece drainable pouch with Type B mouldable adhesive for Stage 1 and 2 followed by pouch with Type A mouldable adhesive for Stage 3

Based on this trial design, predict the completion outcome and termination type (if applicable).